Ztilido Approval Status
- FDA approved: No
- Brand name: Ztilido
- Generic name: lidocaine
- Company: Scilex Pharmaceuticals, Inc.
- Treatment for: Postherpetic Neuralgia
Ztilido (lidocaine patch 1.8%) is a topical anesthetic in development for the treatment of post-herpetic neuralgia, also referred to as after-shingles pain.
FDA Approval Status for Ztilido
|May 15, 2014||Scilex Pharmaceuticals Initiates Pivotal Pharmacokinetic Study for Ztilido|
|Mar 24, 2014||Scilex Pharmaceuticals Announces Filing of Investigational New Drug Application for Ztilido|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.